Benign neoplasm of bone and articular cartilage

DOID EFO MESH SNOMED PheWeb

chondrosarcoma: A malignant cartilaginous matrix-producing mesenchymal neoplasm arising from the bone and soft tissue. It usually affects middle-aged to elderly adults. The pelvic bones, ribs, shoulder girdle, and long bones are the most common sites of involvement. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion.

Endpoint definition

↥

Name	CD2_BENIGN_BONE_CARTILAGE
Long name	Benign neoplasm of bone and articular cartilage
Hospital Discharge registry	ICD-10: D16
Cause of Death registry	ICD-10: D16
Include	CD2_BENIGN_BONE_SCAPULA_LONG_UPPER, CD2_BENIGN_BONE_SHORT_UPPER, CD2_BENIGN_BONE_LONG_LOWER, CD2_BENIGN_BONE_SHORT_LOWER, CD2_BENIGN_BONE_SKULL_FACE, CD2_BENIGN_BONE_LOWER_JAW, CD2_BENIGN_VERTEB_COLUMN, CD2_BENIGN_RIBS_STERNUM_CLAVICLE, CD2_BENIGN_PELVIC_BONES_SACRUM_COCCYX, CD2_BENIGN_BONE_CARTILAGE_NOS
Level in the ICD-hierarchy	2
First defined in version	DF2
Latin name	Neoplasma benignum ossis sive cartilaginis articularis

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	1190	696	494
Unadjusted prevalence (%)	0.55	0.57	0.52
Mean age at first event (years)	38.70	39.45	37.64
Case fatality at 5-years (%)	0.76	0.00	1.82

Longitudinal metrics

	All	Female	Male
Median nb. of events per indiv.	1.0	1.0	1.0
Recurrence at 6 months (%)	26.05	27.87	23.48

Survival analyses between endpoints

↥

Plot

before Benign neoplasm of bone and articular cartilage
after Benign neoplasm of bone and articular cartilage

Loading survival analyses plot…

Table

Loading survival analyses table…

Drugs most likely to be purchased after Benign neoplasm of bone and articular cartilage

↥